CellScape's Series B Round

CellScape raised a round of funding on March 05, 2012.

CellScape has developed whole fetal cell technology to transform prenatal genetic testing using a simple blood test. The company's vision is to make prenatal genetic testing available to every woman w…

Articles about CellScape's Series B Round: